109 results
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
3 Jun 24
Regulation FD Disclosure
7:00am
-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements contained in this presentation that do
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
7 May 24
Zentalis Pharmaceuticals Reports First Quarter 2024 Financial Results and Operational Progress
7:03am
This press release contains forward-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All
8-K
EX-99.1
ZNTL
Zentalis Pharmaceuticals Inc
9 Apr 24
Regulation FD Disclosure
4:30pm
-looking statements within the meaning of the U.S. Private Securities Litigation Reform Act of 1995. All statements contained in this presentation
S-3ASR
bmaykvij
29 Feb 24
Automatic shelf registration
5:14pm
8-K
EX-99.1
kk11dil6s bzv
27 Feb 24
Zentalis Pharmaceuticals Reports Full Year 2023 Financial Results and Operational Updates
7:04am
8-K
EX-99.1
yd3w2gesir5nl97d14r
25 Jan 24
Zentalis Pharmaceuticals Strengthens Management Team with Key Appointments
7:03am
8-K
EX-99.1
bjuie 4ax7
8 Jan 24
Regulation FD Disclosure
7:03am
8-K
EX-99.1
k3083p lwmiisvxtyik
6 Nov 23
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
9:04am
8-K
EX-99.2
r1r45ykx5sia71zdk3
6 Nov 23
Zentalis Pharmaceuticals Reports Third Quarter 2023 Financial Results and Operational Updates
9:04am
8-K
EX-99.1
oa315k emyeoke
13 Sep 23
Regulation FD Disclosure
7:00am
8-K
EX-99.1
qaj7gurv7qrrx1h
9 Aug 23
Regulation FD Disclosure
4:15pm
8-K
EX-99.1
268u ug7owbe
9 Aug 23
Zentalis Pharmaceuticals Reports Second Quarter 2023 Financial Results and Operational Updates
7:03am
424B5
egia7u89yjcyz7cd gml
15 Jun 23
Prospectus supplement for primary offering
4:12pm